Rj. Carey et al., Cocaine and serotonin: a role for the 5-HT1A receptor site in the mediation of cocaine stimulant effects, BEH BRA RES, 126(1-2), 2001, pp. 127-133
Cocaine induced locomotor stimulant effects are generally attributed to coc
aine effects on brain dopamine. In this report, we present evidence that th
e 5-hydroxytryptamine(1A) (5-HT1A) agonist, 8-hydroxy-2-(di-n-propylamino)t
etralin (8-OHDPAT) and the 5-HT1A antagonist, N-[2-[4-(2-methoxyphenyl)-1-"
piperazinyl]ethyl]-N-2-pyridinyl-cycylhexanecarboxaminde maleate (WAY 10063
5) can enhance or block, respectively, the locomotor stimulant effects indu
ced by cocaine. In two separate experiments, rats administered cocaine (10
mg/kg) exhibited a locomotor stimulant effect and decreased grooming behavi
or compared to saline treated rats. Pretreatment with the 5-HT1A agonist, 8
-OHDPAT (0.2 mg/kg) enhanced and pretreatment with the 5-HT1A antagonist, W
AY 100635 (0.4 mg/kg) eliminated the locomotor stimulant effect of cocaine.
Neither the 8-OHDPAT nor WAY 100635 effects were attributable to effects o
n the behavioral baseline. The 8-OHDPAT and WAY 100635 had opposite effects
on Grooming behavior. 8-OHDPAT decreased and WAY 100635 increased grooming
. Neither treatment, however, affected the grooming suppression induced by
cocaine. Ex vivo biochemical measurements indicated that neither 8-OHDPAT o
r WAY 100635 affected brain dopamine metabolism or cocaine availability in
brain. Both treatments affected 5-HT metabolism and altered the effect of c
ocaine on 5-HT metabolism. 8-OHDPAT increased and WAY 100635 decreased coca
ine effects on 5-HT metabolism. Cocaine and 8-OHDPAT but not WAY 100635 inc
reased corticosterone. Altogether, these findings indicate that the 5-HT1A
receptor site may be an important target for the development of pharmaco th
erapies for the treatment of cocaine abuse. (C) 2001 Elsevier Science B.V.
All rights reserved.